middle.news
BCAL opens path to revived Genetic Signatures and Microba merger
2:39pm on Thursday 19th of November, 2026 AEDT
•
Healthcare
Read Story
BCAL opens path to revived Genetic Signatures and Microba merger
2:39pm on Thursday 19th of November, 2026 AEDT
Key Points
60:40 merger ratio in favour of Genetic Signatures
Fiduciary out requested for a superior GSS proposal
Up to $2 million of conditional Microba funding
Support tied to GSS board restructure and chair resignation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE